Gene Expression Clinical Trial
— DGENESOfficial title:
Impact of a Short-Term High Fat Diet Versus A Short-Term Low Fat Diet on Expression of the Key Intestinal Genes Involved in the Cholesterol and Fatty Acid Metabolism Pathways
Verified date | March 2013 |
Source | Laval University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
Dietary fat has been shown to modulate cholesterol and fatty acids homeostasis and several lines of evidence suggest that this effect is associated with changes in the regulation of different genes at the intestine level involved in the cholesterol and fatty acid metabolism pathways. The present study will examine the impact of a short-term high fat diet versus a short-term low fat diet on expression of Niemann-Pick C1-like 1 (NPC1L1), adenosine triphosphate (ATP) binding cassette transporters (ABCG5/8), microsomal triglyceride transfer protein (MTP) and fatty acid transport protein-4 (FATP4), which have been shown to play a critical role in intestinal cholesterol absorption, chylomicron synthesis and dietary lipid absorption. Gene expression studies will be performed on duodenal biopsies. The primary hypothesis is that a short-term high fat diet will significantly decrease duodenal messenger ribonucleic acid (mRNA) levels of NPC1L1, ABCG5/8, MTP and FATP4 as compared with a short-term low fat diet.
Status | Completed |
Enrollment | 12 |
Est. completion date | December 2010 |
Est. primary completion date | May 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Males 18 to 50 years of age - Non-smoker - Body mass index between 20.0 and 30.0 kg/m2 - Plasma LDL-cholesterol levels between the 25th and 75th percentile for their age at day -14 - Plasma triglyceride levels < 1.7 mmol/L (150 mg/dl) at day -14 - Plasma HDL-cholesterol levels between 0.9 (35 mg/dl) and 1.6 mmol/L (60 mg/dl) at day -14 - Subjects must be willing to give written informed consent and able to adhere to the diet schedule and visit schedule - Patients should be otherwise healthy, without elevations in hepatic transaminases or creatine kinase (CK) or abnormal renal function or coagulation Exclusion Criteria: - Patients with extreme dyslipidemias, such as familial hypercholesterolemia will be excluded - Subjects will be excluded if they have cardiovascular disease (CHD, cerebrovascular disease or peripheral arterial disease) or if they are taking other medications known to affect lipoprotein metabolism (eg. steroids, beta blockers, thiazide diuretics, other lipid lowering agents, significant alcohol intake etc.) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | Institute of nutrition and functional food | Quebec city | Quebec |
Lead Sponsor | Collaborator |
---|---|
Laval University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in duodenal mRNA expression of NPC1L1, ABCG5/8, MTP and FATP4. | Six biopsies (3 X 3 mm) will be obtained from the second portion of the duodenum during gastro-duodenoscopy. Biopsy specimen will be stored at -86°C before mRNA extraction. Total RNA will be isolated and used for polymerase chain reaction (PCR) quantification. | At the end of the two 3-days diets (day 3 and day 17). | No |
Secondary | Change in surrogate markers of cholesterol absorption and synthesis. | At the end of the two 3-days diets (day 3 and day 17). | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05620043 -
Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
|
N/A | |
Recruiting |
NCT00918359 -
Heat Intolerance- A Lesson From Global Genomic Response in Lymphocytes
|
N/A | |
Recruiting |
NCT05327400 -
Expression and Clinical Significance of IGHD in Pancreatic Cancer
|
||
Completed |
NCT04868227 -
Scottish Vitamin D Intervention Study
|
N/A | |
Completed |
NCT01681394 -
Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression
|
N/A | |
Completed |
NCT01723410 -
Neural and Physiological Responses to Real-World Experiences
|
N/A | |
Completed |
NCT04415697 -
Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas
|
||
Recruiting |
NCT01321112 -
Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate Mofetil
|
N/A | |
Completed |
NCT01316731 -
MyoGene: Effects of Acute Exercise on (Myokine) Gene Expression in Human Skeletal Muscle
|
N/A | |
Completed |
NCT00859196 -
Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries
|
Phase 4 | |
Recruiting |
NCT04789057 -
Atorvastatin Effect on Reduction of COPD Exacerbations
|
Phase 4 | |
Terminated |
NCT04737044 -
Effects of Antioxidant Sugar vs Granulated Sugar on Metabolic Outcomes in Healthy and Cardio Metabolic Subjects
|
N/A | |
Active, not recruiting |
NCT00972972 -
Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters
|
Phase 0 | |
Withdrawn |
NCT01524523 -
Bone Marrow Aspiration Pain Study
|
N/A | |
Completed |
NCT01052649 -
Gene Expression Monitoring of Mononuclear Cells (MNC) Subpopulations and Immunological Status and Metabolome Defining of Healthy Population
|
N/A |